Amoxicillin Trihydrate + Dicloxacillin Sodium + SerratiopeptidaseThird Party Manufacturing in India

Amoxicillin Trihydrate + Dicloxacillin Sodium + Serratiopeptidase works through a synergistic combination of dual-action antibiotics and a proteolytic enzyme to clear bacterial infections and associated inflammation.

Amoxicillin Trihydrate binds to penicillin-binding proteins to inhibit bacterial cell wall synthesis, leading to cell lysis. Dicloxacillin Sodium blocks penicillinase enzymes that would otherwise degrade amoxicillin, while also killing penicillin-resistant Staphylococcus strains. Serratiopeptidase is a proteolytic enzyme that breaks down abnormal protein aggregates, cellular debris, and inflammatory exudates at the infection site. By digesting these physical barriers, serratiopeptidase reduces tissue swelling and improves microcirculation, which dramatically enhances the penetration of amoxicillin and dicloxacillin into the infected tissues.

Unlike standard antibiotic combinations, this triple formulation speeds up healing by directly targeting both the bacterial pathogen and the tissue inflammation. It is highly effective for painful inflammatory infections of the respiratory tract, bones, and post-surgical wounds.

Therapeutic Uses

Amoxicillin Trihydrate + Dicloxacillin Sodium + Serratiopeptidase is prescribed for the treatment of:

• Inflammatory Ear, Nose, and Throat Infections: Resolves severe sinusitis, tonsillitis, and otitis media accompanied by significant swelling and mucus accumulation.
• Post-Surgical and Traumatic Wound Infections: Prevents bacterial colonization and reduces painful localized edema at the wound site.
• Bone and Joint Infections: Used in osteomyelitis and dental abscesses to enhance antibiotic penetration into hard-to-reach tissues.
• Severe Skin and Soft Tissue Infections: Treats abscesses, cellulitis, and carbuncles with concurrent inflammation.

Why Manufacturers Choose Amoxicillin Trihydrate + Dicloxacillin Sodium + Serratiopeptidase

This triple-action combination is highly favored by clinicians in India for managing painful, swollen infections. By combining two antibiotics with an anti-inflammatory enzyme, it offers a single-tablet solution that improves patient compliance and reduces treatment costs. For pharma brands and PCD distributors, this represents a premium, high-demand formulation with excellent margins. Sourcing this molecule from WHO-GMP certified facilities is crucial because serratiopeptidase is temperature-sensitive and requires specialized handling during compression and Alu-Alu blister packaging to preserve enzyme activity.

This makes the combination one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.